Scroll to top

CLINUVEL Chair to Retire Following FDA Approval

CLINUVEL PHARMACEUTICALS LTD today announced that Mr Stan McLiesh will retire from his role as Non-Executive Director and Chair of the Board on 30 November 2019. Non-Executive Director Mr Willem Blijdorp has been elected Chair and will take on the role on 30 November 2019.

Download PDF

We use cookies to give you the best experience.